Skip To Main Content
Sebile Guler Cekic on Muck Rack

Sebile Guler Cekic

Turkey
As seen in: Wiley Online Library, Reproductive BioMedicine Online
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sebile Guler

Contact Sebile Guler, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Extraskeletal myxoid chondrosarcoma mimicking mucinous ovarian cancer: A case report

|
By Sebile Guler Cekic, Ömer Faruk Atay, Volkan Ülker, Özgür Akbayir
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interests for this article. REFERENCES 1, , , , , , et al. The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. Clin Exp Metastasis. 2017; 34(5): 295–307. https://doi.org/10.1007/s10585-017-9856-8 2, , . Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer. Gynecol Oncol.
Open in Who Shared Issue with article?

Do hematologic malignancies cause a barrier for sentinel lymph node mapping in endometrial cancer? A case report

|
By Ceren Ünal, Sebile Guler Cekic, Pınar Bulutay, Şevval Berfin Topkara
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT The authors report no conflict of interest. REFERENCES 1, , , , , , et al. The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis. J Gynecol Oncol. 2022; 33(5):e66. 2, , , , , , et al. Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate- and high-grade endometrial cancer staging. JAMA Surg. 2021; 156(2): 157–164. 3, , , , , , et al.
Open in Who Shared Issue with article?

PROGESTINS vs GONADOTROPIN RELEASING HORMONE ANALOGUES FOR PITUITARY SUPPRESSION DURING OVARIAN STIMULATION FOR ASSISTED REPRODUCTIVE TECHNOLOGY, A SYSTEMATIC REVIEW AND META-ANALYSIS

|
By Engin Turkgeldi, Polexa Alexandru, Sebile Guler Cekic, Sule Yildiz
| Reproductive BioMedicine Online Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Figure 1 Study Flow diagram. Figure 2 Progestin vs GnRH Antagonists, live birth or ongoing pregnancy rate per embryo transfer. Figure 3 Progestin vs GnRH Antagonists, clinical pregnancy rate per embryo transfer. Figure 4 Progestin vs GnRH Antagonist, miscarriage rate per pregnancy. Figure 5 Progestins vs GnRH agonists, live birth rate per transfer.
Open in Who Shared Issue with article?
See all 3 articles